Marginal zone lymphoma treatments may include treatment for infections, radiation therapy, immunotherapy, chemotherapy, surgery, targeted therapy, CAR-T cell therapy and bone marrow transplant, also called bone marrow stem cell transplant. Which treatment is best for you depends on the extent of your cancer, called the stage. Your healthcare team also considers how quickly the cancer is growing, your overall health and what you prefer.
Treatment for infections
If you have extranodal marginal zone lymphoma in the stomach that's caused by H. pylori, you may be given medicines to treat the infection. Medicines may include antibiotics and proton pump inhibitors. Treating H. pylori can make the cancer shrink or go away in most people.
Antiviral medicines may be given to people with lymphoma caused by hepatitis C to treat the infection. Treating hepatitis C can make the cancer shrink or go away.
Radiation therapy
Radiation therapy treats cancer with powerful energy beams. The energy can come from X-rays, protons or other sources. During radiation therapy, you lie on a table while a machine moves around you. The machine directs radiation to precise points on your body.
Radiation therapy may be used as a first line treatment for extranodal MZL and early-stage nodal MZL. Radiation therapy also may be used to ease symptoms and improve quality of life for people with advanced nodal MZL or splenic MZL that has come back after treatment.
Immunotherapy
Immunotherapy for cancer is a treatment with medicine that helps the body's immune system kill cancer cells. The immune system fights off diseases by attacking germs and other cells that shouldn't be in the body. Cancer cells survive by hiding from the immune system. Immunotherapy helps the immune system cells find and kill the cancer cells.
Immunotherapy may be used as a first line treatment for marginal zone lymphoma. It is usually combined with chemotherapy. Immunotherapy also may be used for advanced cancer that has come back after treatment, known as relapsed marginal zone lymphoma, or when other treatments haven't worked, known as refractory marginal zone lymphoma. Immunotherapy may be used alone for older people or people who may not tolerate other treatments well.
Chemotherapy
Chemotherapy treats cancer with strong medicines. There are many chemotherapy medicines. Most chemotherapy medicines are given through a vein. Some come in pill form.
Chemotherapy may be used as a first line treatment for marginal zone lymphoma. It is usually combined with immunotherapy. Chemotherapy also may be used for advanced cancer or cancer that has come back after treatment, known as relapsed marginal zone lymphoma. Chemotherapy may be used after radiation therapy for people with extranodal MZL when other treatments haven't worked, known as refractory extranodal MZL.
Surgery
For splenic marginal zone lymphoma (SMZL) that causes severe symptoms, surgery to remove the spleen, called a splenectomy, may be done. It also may be an option for SMZL that turns into a more aggressive type of lymphoma. SMZL that doesn't cause symptoms may not need treatment right away.
Surgery may be an option for early-stage cancers outside of the lymph nodes such as in the lung, breast, thyroid, and colon or small bowel. Surgery also may be used if the cancer is causing life-threatening side effects such as a blockage or hemorrhage.
Targeted therapy
Targeted therapy for cancer is a treatment that uses medicines that attack specific chemicals in the cancer cells. By blocking these chemicals, targeted treatments can cause cancer cells to die.
For marginal zone lymphoma, targeted therapy may be used as a first line treatment. It is often combined with immunotherapy. Targeted therapy may be used when cancer comes back after treatment, known as relapsed marginal zone lymphoma. Targeted therapy also may be an option when other treatments haven't worked. This is known as refractory marginal zone lymphoma.
Bone marrow transplant
A bone marrow transplant, also called a bone marrow stem cell transplant, involves putting healthy bone marrow stem cells into the body. These cells replace cells hurt by chemotherapy and other treatments.
Sometimes, a bone marrow transplant can be used for marginal zone lymphoma that has come back after treatment, called relapsed marginal zone lymphoma.
Monitoring after treatment
Marginal zone lymphoma has a risk of coming back after treatment, known as a relapse. After treatment, you may have follow-up appointments to monitor for relapse. Depending on your type of MZL, you may need follow-up endoscopies, biopsies, blood tests and imaging tests.
Side effects of treatment
Treatments for marginal zone lymphoma may have side effects. These may include nausea, vomiting, fatigue, fever, rash, diarrhea and more. Harmful side effects from treatments may include:
-
Bone marrow suppression. When the bone marrow is suppressed, it can't produce enough blood cells, including white blood cells. White blood cells help fight infections, so if you have a lower amount, you are at a higher risk of infections.
-
Febrile neutropenia. Febrile neutropenia is a serious condition that can happen in people being treated for cancer. Febrile means having a fever. Neutropenia means having a low number of neutrophils, which are a type of white blood cell that helps fight infections. In febrile neutropenia, the body is trying to fight an infection but doesn't have enough neutrophils.
-
Medicine toxicity. Some medicines used to treat cancer can be harmful to the body. They can cause organ damage and other issues. Whether a medicine is toxic depends on the type and how much you take. There are many different medicine options, so your healthcare team can work with you to find the best medicines for you.
-
Tumor lysis syndrome. Tumor lysis syndrome is a serious condition that can happen when cancer cells break down quickly after treatment. When these cells die, they release substances into the bloodstream that can overwhelm the body. This can lead to issues with the kidneys and other organs. Medicines may be given to treat or prevent harmful side effects.